Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Morgantown, West Virginia 26505


Purpose:

The purpose of this study is to evaluate the effects of various doses of nebivolol in patients with mild to moderate hypertension.


Study summary:

This was a multi-center, randomized, double-blind, parallel group, placebo-controlled study of nebivolol over a range of doses in patients with mild to moderate hypertension. The study consisted of 2 phases: screening/washout/single-blind placebo run-in followed by randomization/double-blind treatment. During the double-blind phase, patients received nebivolol or placebo. Patients had 7 scheduled clinical visits during the study.


Criteria:

Inclusion Criteria: - An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline Exclusion Criteria: - Recent myocardial infarction or stroke - Secondary hypertension - Contraindications to beta-blocker treatment or discontinuation of current antihypertensive therapy - Pregnancy, nursing, or women of child-bearing potential not using appropriate contraception


NCT ID:

NCT00200460


Primary Contact:

Study Director
Betty S. Riggs, MD, MBA
Mylan Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Morgantown, West Virginia 26505
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.